Advances in Radiation Oncology (Oct 2024)

Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial

  • Justin Oh, MD,
  • Lawrie Skinner, PhD,
  • Paulina M. Gutkin, BS,
  • Alice Jiang, BA,
  • Sarah S. Donaldson, MD,
  • Billy W. Loo, Jr, MD, PhD,
  • Yi Peng Wang, BA,
  • Agnes Ewongwo, MD,
  • Jeremy S. Bredfeldt, PhD,
  • John C. Breneman, MD,
  • Louis S. Constine, MD,
  • Austin M. Faught, PhD,
  • Daphne Haas-Kogan, MD,
  • Jordan A. Holmes, MD,
  • Matthew Krasin, MD,
  • Charlene Larkin, CCLS,
  • Karen J. Marcus, MD,
  • Peter G. Maxim, PhD,
  • Shearwood McClelland, III, MD,
  • Blair Murphy, MD,
  • Joshua D. Palmer, MD,
  • Stephanie M. Perkins, MD,
  • Colette J. Shen, MD,
  • Stephanie Terezakis, MD,
  • Karl Bush, PhD,
  • Susan M. Hiniker, MD

Journal volume & issue
Vol. 9, no. 10
p. 101589

Abstract

Read online

Purpose: The Audiovisual-Assisted Therapeutic Ambience in Radiotherapy (AVATAR) trial was a prospective multicenter study (NCT03991156) examining the combination of video immersion with radiation therapy and was successfully conducted through the collaboration of pediatric radiation oncology teams at 10 institutions independent of any pre-existing consortium. We sought to analyze and report the methodology of trial conception and development, process map, and cost. Methods and Materials: The study enrolled patients aged 3 to 10 years preparing to undergo radiation therapy, integrated the combination of AVATAR-based video immersion with radiation therapy at each institution, and offered AVATAR use as an alternative to anesthesia, with rates of anesthesia use and outcomes of serial standardized anxiety and quality-of-life assessments assessed among the 81 children enrolled. A process map was created based on the trial timeline with the following components: study development time (time from conception of the trial to the accrual of the first patient, including design phase, agreement and approval phase, and site preparation phase), and accrual duration time (time from the first to last accrual). Costs and institutional success rates were calculated. Results: Time from inception of study to last accrual was 3.6 years (1313 days). The study development time was 417 days (31.7%), and accrual duration time was 896 days (68.3%), with the final 50% of accrual occurring in <6 months. Equipment cost was approximately $550 per institution and was covered by funding from the lead study institution. All 10 centers were successful with AVATAR implementation, defined as ≥50% of patients able to avoid anesthesia with the use of AVATAR, including centers with both photon and proton therapy. Conclusions: This report elaborates on the methodology and timeline of trial conception and development using data from a previously published supportive care study combining video immersion with radiation therapy among 10 cooperating pediatric oncology institutions. It highlights the potential for multicenter collaborations on prospective trials integrating supportive care therapies with radiation therapy.